In the DURATION-8 trial, dapagliflozin as monotherapy and in combination with EX-QW showed trends favoring improvements in LFC, glucose and lipid metabolism, and liver fibrosis scores at the end of the study, but no significant statistical differences were observed
Started with nutrition and behaviour change, moved into GLP-1 prescribing, and now expanding into the same verticals the longevity space has been quietly building in, energy, hormonal health, inflammation, sleep
For the small minority of adults who suffer night terrors, there are different considerations
allulose triggered the release of GLP-1 (glucagon-like peptide 1), which stimulates insulin release, improves insulin sensitivity, and helps reduce feelings of hunger